Founded by pharmaceutical scientist Shankar Hariharan, Scienture, LLC is a New York-based specialty pharmaceutical company built around closing gaps in patient care. Its team develops and commercializes selectively designed therapies intended to make treatment more accessible and easier to use, including Arbli for patients who need a ready-to-use liquid form of losartan. Scienture combines pharmaceutical research with an agile commercialization model focused on overlooked patient needs.
Saptalis Pharmaceuticals, LLCFounded in 2015, Saptalis Pharmaceuticals is a privately held U.S. specialty pharmaceutical company known for developing prescription therapies in niche areas, particularly for patients who need more specialized dosage forms. Its Hauppauge, New York operation supports drug development and manufacturing for pediatric and geriatric care, including oral liquids and sterile ophthalmic products.HAUPPAUGE, NY
Emphascience, IncFounded in 2010 by husband-and-wife scientists Rebanta and Susen Bandyopadhyay, Emphascience is a private pharmaceutical company known for rethinking established medicines rather than discovering entirely new molecules. Its researchers develop formulations that can make proven drugs easier to use or extend their therapeutic applications, working with marketing partners as products advance through development and regulatory review.PITTSFORD, NY
Kokomo Pharma, LLCKokomo Pharma is a Cincinnati-based specialty pharmaceutical company focused on bringing niche prescription medicines to patients with challenging conditions and unmet medical needs. It builds partnerships to commercialize products in the United States, with patient satisfaction and access at the center of its stated mission.CINCINNATI, OH
Laxxon MedicalFounded in 2017 by pharmaceutical professionals, Laxxon Medical develops 3D screen-printed drug delivery systems through its proprietary SPID®-Technology. Headquartered in New York City with research and development facilities in Jena, Germany, the company works with pharmaceutical partners on oral dosage forms that can control how active ingredients are released, including projects aimed at making injectable therapies available by mouth. Its platform supports development from small clinical batches through production at up to 1.5 million units per day.NEW YORK, NY